Role of Sentinel Lymph Node Biopsy in the Management of Merkel Cell Carcinoma
Author(s) -
Eric P. Arruda,
Kevin Higgins
Publication year - 2012
Publication title -
journal of skin cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.309
H-Index - 10
eISSN - 2090-2905
pISSN - 2090-2913
DOI - 10.1155/2012/176173
Subject(s) - merkel cell carcinoma , medicine , sentinel lymph node , sentinel node , radiation therapy , biopsy , disease , dermatology , etiology , skin cancer , lymphatic system , oncology , surgery , carcinoma , cancer , pathology , breast cancer
Merkel cell carcinoma (MCC) is a rare and typically aggressive form of skin cancer. It most commonly affects the elderly and has a predilection for the sun-exposed skin of the head and neck region. Other etiological factors include immune suppression, organ transplantation, and polyoma virus infection. MCC has a propensity to spread to regional lymphatics with a high locoregional recurrence rate. Since its discovery in 1972, treatment paradigms have shifted, with no consensus on optimal management strategies. Currently, standard of care includes surgical intervention to the primary and locoregional site with adjuvant radiotherapy for high-risk disease. In this paper, we discuss the history, pathology, and epidemiology of this rare disease with a focus on the evidentiary basis of treatment protocols. The use of sentinel lymph node biopsy as a management option will be the focus of this paper.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom